Effect of Pharmacist Provided Drug Information Services After Hospital Discharge
Effect of Pharmacist Provided Drug Information Services After Hospital Discharge: Patient Satisfaction and Sense Of Security Regarding Drug Treatment.
Objective:
The aim of this study is to evaluate if offering drug counseling from a hospital pharmacy increases patient satisfaction and sense of security regarding drug treatment after hospital discharge.
Visão geral do estudo
Descrição detalhada
Method and design:
This study was estimated to include 250 participants in a clinical randomized controlled trial. The participants were included from the Acute Medical Ward and the Department of Respiratory Medicine at Bispebjerg Hospital when discharged. The participants were randomized to one of two groups with unequal sizes: the control (50 participants) or intervention group (200 participants). This study used blocked randomization with block sizes of 5/10/15/20/25. The control group received the normal care following the Danish standard procedure. Participants in the intervention group also received the normal care but was also offered the possibility to contact a hospital pharmacy department by phone or mail and ask questions regarding drug-related issues.
Data for the primary outcome measures was collected 14 days after discharge through structured phone interviews. An interview guide with a semi-structured questionnaire and already validated questions were developed, pre-tested and optimized. The participants were asked to answer open-ended questions, closed-ended question and rate statements or questions on a five-point scale.
The participants in the control group were asked to answer 13 items (seven questions or statements on a five-point scale, four closed-ended questions and two open-ended questions).
The participants in the intervention group who did not make any queries were asked the same questions as the participants in the control group and additionally three closed-ended questions. A total of 16 items.
The participants in the intervention group who made queries were asked the same questions as the participants in the intervention group who did not make any queries and additionally five questions on a five-point scale, four closed-ended and one open-ended question. A total of 27 items.
The effect of the drug counseling regarding patient safety was evaluated by a pharmaceutical assessment in which it was assessed whether the drug counseling had potentially prevented a drug-related problem.
Quantitative data from the phone interviews will be analyzed in Microsoft excel with descriptive statistics and simple parametric statistics. An analysis will determine whether there is a difference in the primary outcome measures.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
København NV
-
Copenhagen, København NV, Dinamarca, 2400
- Capital Regions Hospital Pharmacy
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients discharged from the acute medical ward and department of respiratory medicine at Bispebjerg Hospital.
- Patients discharged to own home.
- Can speak the danish language.
- ≥18 years old.
- Can be contacted by phone.
Exclusion Criteria:
- Cognitive and communicative problems (e.g. dementia, aphasia, suicidal) or other barriers that unable the participant to use the intervention service.
- Patient does not answer phone within five attempts on five different days, when trying to conduct patient interview.
- Cognitive and communicative problems that unable the participant to answer questions in the patient interview.
- Deceased or readmitted before patient interview.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Control group
Participants in the control group received the normal care following the Danish standard procedure.
|
|
|
Comparador Ativo: Intervention group
Participants in the intervention group received the normal care following the Danish stadard procedure.
Additionally the participants was also offered the possibility to contact a hospital pharmacy department by phone or mail for drug counseling.
|
Participants can contact a hospital pharmacy department by phone or mail and ask questions regarding drug-related issues.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Sense of security regarding drug treatment and satisfaction with drug counseling.
Prazo: 2-4 weeks after discharge.
|
The questionnaire comprised closed-ended questions, open-ended questions and questions or statements where the respondents were asked to rate the questions or statements on a five-point scale.
The scale used is a attitude measurement scale that assess attitudes by presenting respondents with sentences that state beliefs about the particular attitude being measured.
The respondents then decide to what extent he or she agrees with the statement.
The responses are divided numerically into a series of ordered responses.
Ratings: 1 = not at all, 2 = to a small extent, 3 = to some extent, 4 = to a great extent, 5 = to a very great extent.
|
2-4 weeks after discharge.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Number of medications by admission.
Prazo: Within one week after discharge.
|
Number of medications will be read in admission report.
|
Within one week after discharge.
|
|
Number of medications by discharge.
Prazo: Within one week after discharge.
|
Number of medications will be read in discharge report..
|
Within one week after discharge.
|
|
Number of patients that received medication review by pharmacist during admission.
Prazo: Within one week after discharge.
|
The patient's journal will be searched for a medication review.
|
Within one week after discharge.
|
|
Number of patients that received help with medication at home after discharge.
Prazo: Within one week after discharge.
|
The patient's journal will be searched for information regarding help with medication at home.
|
Within one week after discharge.
|
|
Number of enquiries.
Prazo: Directly after the patient received drug counseling.
|
Patient enquiries will be classified to one of the predefined categories: adverse effects, choice of therapy, dosage and administration, interactions, product information, storage and handling, indication or other.
|
Directly after the patient received drug counseling.
|
|
Number of potentially prevented drug-related problems.
Prazo: Directly after the patient received drug counseling.
|
The pharmacist that performed the drug counseling assessed whether the drug counseling had potentially prevented a drug-related problem.
|
Directly after the patient received drug counseling.
|
|
Cause of hospitalization.
Prazo: Within one week after discharge.
|
The patient's journal will be searched for cause of hospitalization.
|
Within one week after discharge.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Tim E Vejborg, M.Sc.Pharm, Region Hovedstadens Apotek
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- H-18003889
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .